La découverte de nouveaux procédés biotechnologiques remet en question la capacité de la loi de fournir une protection suffisante de l'être humain dès le commencement de sa vie. Ces nouvelles méthodes, comme la méthode CRISPR/Cas9, également connue sous le nom de « genome editing », le don de mitochondries et, finalement, la création de cellules souches pluripotentes induites humaines (cellules hiPS) permettent de manipuler et d'influencer de manière fondamentale la constitution génétique de la progéniture et des générations futures. En vue de ces développements, cette thèse vise à élaborer un projet de loi adressé au législateur allemand en prenant compte de deux aspects : d'un côté, sur la base d'une analyse comparative du droit allemand ...
Discovery of CRISPR/Cas9 technology produced a revolution in human medicine, because of the availabi...
The problem of legal regulation of gene editing in recent years has obviously become global in natur...
CRISPR/Cas is a bacterial defense system whose application to gene editing was discovered in 2014. A...
CRISPR/Cas9 is a new genome modification tool that is affordable and easy to use. Its possible appli...
Commonly, the regulation on germline editing in Europe is described through the two prohibitions: th...
The advent of the CRISPR/Cas9 class of genome editing tools is transforming not just science and med...
Le développement des biotechnologies en santé a été inévitablement suivi du débat complexe relatif à...
Germany lacks a comprehensive legal framework which deals with the various problems raised by recent...
International audienceThe French legal framework on genome editing of human iPS cells is complicated...
The development of biotechnologies applied to health has inevitably be followed by a large debate re...
Technological developments in gene editing raise high expectations for clinical applications, includ...
Technological developments in gene editing raise high expectations for clinical applications, includ...
Technological developments in gene editing raise high expectations for clinical applications, includ...
Goal and approach This report presents current legal regulation of human genetics and human genomic...
Discovery of CRISPR/Cas9 technology produced a revolution in human medicine, because of the availabi...
The problem of legal regulation of gene editing in recent years has obviously become global in natur...
CRISPR/Cas is a bacterial defense system whose application to gene editing was discovered in 2014. A...
CRISPR/Cas9 is a new genome modification tool that is affordable and easy to use. Its possible appli...
Commonly, the regulation on germline editing in Europe is described through the two prohibitions: th...
The advent of the CRISPR/Cas9 class of genome editing tools is transforming not just science and med...
Le développement des biotechnologies en santé a été inévitablement suivi du débat complexe relatif à...
Germany lacks a comprehensive legal framework which deals with the various problems raised by recent...
International audienceThe French legal framework on genome editing of human iPS cells is complicated...
The development of biotechnologies applied to health has inevitably be followed by a large debate re...
Technological developments in gene editing raise high expectations for clinical applications, includ...
Technological developments in gene editing raise high expectations for clinical applications, includ...
Technological developments in gene editing raise high expectations for clinical applications, includ...
Goal and approach This report presents current legal regulation of human genetics and human genomic...
Discovery of CRISPR/Cas9 technology produced a revolution in human medicine, because of the availabi...
The problem of legal regulation of gene editing in recent years has obviously become global in natur...
CRISPR/Cas is a bacterial defense system whose application to gene editing was discovered in 2014. A...